Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for AAUACUG
Z-value: 1.48
Motif logo
miRNA associated with seed AAUACUG
| Name | miRBASE accession |
|---|---|
|
hsa-miR-200b-3p
|
MIMAT0000318 |
|
hsa-miR-200c-3p
|
MIMAT0000617 |
|
hsa-miR-429
|
MIMAT0001536 |
Activity profile of AAUACUG motif
Sorted Z-values of AAUACUG motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_-_151344172 | 22.56 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
RND3
|
Rho family GTPase 3 |
| chrX_+_64887512 | 22.04 |
ENST00000360270.5
|
MSN
|
moesin |
| chr12_-_109125285 | 19.76 |
ENST00000552871.1
ENST00000261401.3 |
CORO1C
|
coronin, actin binding protein, 1C |
| chr3_-_120170052 | 19.45 |
ENST00000295633.3
|
FSTL1
|
follistatin-like 1 |
| chr9_+_112810878 | 17.25 |
ENST00000434623.2
ENST00000374525.1 |
AKAP2
|
A kinase (PRKA) anchor protein 2 |
| chr12_-_15942309 | 16.75 |
ENST00000544064.1
ENST00000543523.1 ENST00000536793.1 |
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
| chr17_-_62658186 | 16.30 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
| chr6_-_122792919 | 16.01 |
ENST00000339697.4
|
SERINC1
|
serine incorporator 1 |
| chr5_+_17217669 | 15.67 |
ENST00000322611.3
|
BASP1
|
brain abundant, membrane attached signal protein 1 |
| chr7_-_94285511 | 15.62 |
ENST00000265735.7
|
SGCE
|
sarcoglycan, epsilon |
| chr9_+_112542572 | 15.51 |
ENST00000374530.3
|
PALM2-AKAP2
|
PALM2-AKAP2 readthrough |
| chr1_-_95392635 | 15.35 |
ENST00000538964.1
ENST00000394202.4 ENST00000370206.4 |
CNN3
|
calponin 3, acidic |
| chr2_-_36825281 | 14.06 |
ENST00000405912.3
ENST00000379245.4 |
FEZ2
|
fasciculation and elongation protein zeta 2 (zygin II) |
| chr22_-_36236265 | 13.71 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
| chr1_+_182992545 | 13.43 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
| chr3_-_134093395 | 12.94 |
ENST00000249883.5
|
AMOTL2
|
angiomotin like 2 |
| chr6_+_114178512 | 12.88 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
| chr12_-_46766577 | 12.30 |
ENST00000256689.5
|
SLC38A2
|
solute carrier family 38, member 2 |
| chr12_+_69004619 | 11.94 |
ENST00000250559.9
ENST00000393436.5 ENST00000425247.2 ENST00000489473.2 ENST00000422358.2 ENST00000541167.1 ENST00000538283.1 ENST00000341355.5 ENST00000537460.1 ENST00000450214.2 ENST00000545270.1 ENST00000538980.1 ENST00000542018.1 ENST00000543393.1 |
RAP1B
|
RAP1B, member of RAS oncogene family |
| chr2_+_114647504 | 11.76 |
ENST00000263238.2
|
ACTR3
|
ARP3 actin-related protein 3 homolog (yeast) |
| chr5_-_133561752 | 11.73 |
ENST00000519718.1
ENST00000481195.1 |
CTD-2410N18.5
PPP2CA
|
S-phase kinase-associated protein 1 protein phosphatase 2, catalytic subunit, alpha isozyme |
| chr14_-_64010046 | 11.15 |
ENST00000337537.3
|
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform |
| chrX_+_150151752 | 10.99 |
ENST00000325307.7
|
HMGB3
|
high mobility group box 3 |
| chr8_+_22224811 | 10.97 |
ENST00000381237.1
|
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
| chr3_+_141106643 | 10.79 |
ENST00000514251.1
|
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chr20_+_43514315 | 10.70 |
ENST00000353703.4
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta |
| chrX_+_114827818 | 10.68 |
ENST00000420625.2
|
PLS3
|
plastin 3 |
| chr9_+_33265011 | 10.59 |
ENST00000419016.2
|
CHMP5
|
charged multivesicular body protein 5 |
| chr5_-_57756087 | 10.39 |
ENST00000274289.3
|
PLK2
|
polo-like kinase 2 |
| chr7_+_5632436 | 10.16 |
ENST00000340250.6
ENST00000382361.3 |
FSCN1
|
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) |
| chr5_+_138629417 | 10.13 |
ENST00000510056.1
ENST00000511249.1 ENST00000503811.1 ENST00000511378.1 |
MATR3
|
matrin 3 |
| chr1_-_225615599 | 10.02 |
ENST00000421383.1
ENST00000272163.4 |
LBR
|
lamin B receptor |
| chr3_+_159557637 | 9.83 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
| chr12_-_106641728 | 9.78 |
ENST00000378026.4
|
CKAP4
|
cytoskeleton-associated protein 4 |
| chr17_-_76870222 | 9.78 |
ENST00000585421.1
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
| chr3_+_158991025 | 9.68 |
ENST00000337808.6
|
IQCJ-SCHIP1
|
IQCJ-SCHIP1 readthrough |
| chr2_+_102508955 | 9.55 |
ENST00000414004.2
|
FLJ20373
|
FLJ20373 |
| chr12_+_72148614 | 9.52 |
ENST00000261263.3
|
RAB21
|
RAB21, member RAS oncogene family |
| chr17_+_66508537 | 9.33 |
ENST00000392711.1
ENST00000585427.1 ENST00000589228.1 ENST00000536854.2 ENST00000588702.1 ENST00000589309.1 |
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chr6_-_108395907 | 9.23 |
ENST00000193322.3
|
OSTM1
|
osteopetrosis associated transmembrane protein 1 |
| chr1_+_25071848 | 9.22 |
ENST00000374379.4
|
CLIC4
|
chloride intracellular channel 4 |
| chr1_+_181057638 | 8.98 |
ENST00000367577.4
|
IER5
|
immediate early response 5 |
| chr3_+_171758344 | 8.79 |
ENST00000336824.4
ENST00000423424.1 |
FNDC3B
|
fibronectin type III domain containing 3B |
| chr5_+_71403061 | 8.79 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
| chr6_-_10415470 | 8.76 |
ENST00000379604.2
ENST00000379613.3 |
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
| chr10_-_27443155 | 8.74 |
ENST00000427324.1
ENST00000326799.3 |
YME1L1
|
YME1-like 1 ATPase |
| chr14_+_62229075 | 8.67 |
ENST00000216294.4
|
SNAPC1
|
small nuclear RNA activating complex, polypeptide 1, 43kDa |
| chr1_+_110091189 | 8.49 |
ENST00000369851.4
|
GNAI3
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 |
| chr6_-_17706618 | 8.48 |
ENST00000262077.2
ENST00000537253.1 |
NUP153
|
nucleoporin 153kDa |
| chr13_-_40177261 | 8.08 |
ENST00000379589.3
|
LHFP
|
lipoma HMGIC fusion partner |
| chr6_+_30687978 | 7.97 |
ENST00000327892.8
ENST00000435534.1 |
TUBB
|
tubulin, beta class I |
| chr14_+_57735614 | 7.94 |
ENST00000261558.3
|
AP5M1
|
adaptor-related protein complex 5, mu 1 subunit |
| chr2_-_47168906 | 7.72 |
ENST00000444761.2
ENST00000409147.1 |
MCFD2
|
multiple coagulation factor deficiency 2 |
| chr3_-_182698381 | 7.63 |
ENST00000292782.4
|
DCUN1D1
|
DCN1, defective in cullin neddylation 1, domain containing 1 |
| chr3_-_123603137 | 7.56 |
ENST00000360304.3
ENST00000359169.1 ENST00000346322.5 ENST00000360772.3 |
MYLK
|
myosin light chain kinase |
| chrX_-_20284958 | 7.52 |
ENST00000379565.3
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| chr10_+_105726862 | 7.49 |
ENST00000335753.4
ENST00000369755.3 |
SLK
|
STE20-like kinase |
| chr21_-_15755446 | 7.48 |
ENST00000544452.1
ENST00000285667.3 |
HSPA13
|
heat shock protein 70kDa family, member 13 |
| chr3_-_33686743 | 7.14 |
ENST00000333778.6
ENST00000539981.1 |
CLASP2
|
cytoplasmic linker associated protein 2 |
| chr3_-_176914238 | 7.11 |
ENST00000430069.1
ENST00000428970.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr11_-_9286921 | 7.08 |
ENST00000328194.3
|
DENND5A
|
DENN/MADD domain containing 5A |
| chr4_+_20255123 | 7.01 |
ENST00000504154.1
ENST00000273739.5 |
SLIT2
|
slit homolog 2 (Drosophila) |
| chr2_+_187350883 | 6.96 |
ENST00000337859.6
|
ZC3H15
|
zinc finger CCCH-type containing 15 |
| chr15_-_49447835 | 6.88 |
ENST00000388901.5
ENST00000299259.6 |
COPS2
|
COP9 signalosome subunit 2 |
| chr8_-_103668114 | 6.87 |
ENST00000285407.6
|
KLF10
|
Kruppel-like factor 10 |
| chr6_-_24721054 | 6.87 |
ENST00000378119.4
|
C6orf62
|
chromosome 6 open reading frame 62 |
| chr7_-_35077653 | 6.81 |
ENST00000310974.4
|
DPY19L1
|
dpy-19-like 1 (C. elegans) |
| chr17_-_53499310 | 6.72 |
ENST00000262065.3
|
MMD
|
monocyte to macrophage differentiation-associated |
| chr8_+_41348072 | 6.68 |
ENST00000405786.2
|
GOLGA7
|
golgin A7 |
| chr10_+_31608054 | 6.68 |
ENST00000320985.10
ENST00000361642.5 ENST00000560721.2 ENST00000558440.1 ENST00000424869.1 ENST00000542815.3 |
ZEB1
|
zinc finger E-box binding homeobox 1 |
| chr1_+_84543734 | 6.62 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
| chr6_+_52535878 | 6.61 |
ENST00000211314.4
|
TMEM14A
|
transmembrane protein 14A |
| chrX_-_110038990 | 6.55 |
ENST00000372045.1
ENST00000394797.4 |
CHRDL1
|
chordin-like 1 |
| chr12_+_12870055 | 6.53 |
ENST00000228872.4
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
| chr19_-_11308190 | 6.48 |
ENST00000586659.1
ENST00000592903.1 ENST00000589359.1 ENST00000588724.1 ENST00000432929.2 |
KANK2
|
KN motif and ankyrin repeat domains 2 |
| chr6_+_119215308 | 6.47 |
ENST00000229595.5
|
ASF1A
|
anti-silencing function 1A histone chaperone |
| chr1_-_1624083 | 6.24 |
ENST00000378662.1
ENST00000234800.6 |
SLC35E2B
|
solute carrier family 35, member E2B |
| chr16_-_65155833 | 6.05 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
| chr20_-_48770174 | 5.97 |
ENST00000341698.2
|
TMEM189-UBE2V1
|
TMEM189-UBE2V1 readthrough |
| chr15_-_64673630 | 5.97 |
ENST00000558008.1
ENST00000559519.1 ENST00000380258.2 |
KIAA0101
|
KIAA0101 |
| chr14_+_67826709 | 5.97 |
ENST00000256383.4
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
| chr9_+_2621798 | 5.95 |
ENST00000382100.3
|
VLDLR
|
very low density lipoprotein receptor |
| chr10_+_22610124 | 5.83 |
ENST00000376663.3
|
BMI1
|
BMI1 polycomb ring finger oncogene |
| chr11_+_111807863 | 5.81 |
ENST00000440460.2
|
DIXDC1
|
DIX domain containing 1 |
| chr3_+_180630090 | 5.75 |
ENST00000357559.4
ENST00000305586.7 |
FXR1
|
fragile X mental retardation, autosomal homolog 1 |
| chr1_-_59249732 | 5.74 |
ENST00000371222.2
|
JUN
|
jun proto-oncogene |
| chr20_+_52824367 | 5.73 |
ENST00000371419.2
|
PFDN4
|
prefoldin subunit 4 |
| chr18_-_21166841 | 5.71 |
ENST00000269228.5
|
NPC1
|
Niemann-Pick disease, type C1 |
| chrX_-_131352152 | 5.65 |
ENST00000342983.2
|
RAP2C
|
RAP2C, member of RAS oncogene family |
| chr22_+_39898325 | 5.59 |
ENST00000325301.2
ENST00000404569.1 |
MIEF1
|
mitochondrial elongation factor 1 |
| chr1_+_11072696 | 5.57 |
ENST00000240185.3
ENST00000476201.1 |
TARDBP
|
TAR DNA binding protein |
| chr20_-_48729670 | 5.56 |
ENST00000371657.5
|
UBE2V1
|
ubiquitin-conjugating enzyme E2 variant 1 |
| chr5_-_142783175 | 5.52 |
ENST00000231509.3
ENST00000394464.2 |
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| chr2_-_152684977 | 5.50 |
ENST00000428992.2
ENST00000295087.8 |
ARL5A
|
ADP-ribosylation factor-like 5A |
| chr2_-_38303218 | 5.48 |
ENST00000407341.1
ENST00000260630.3 |
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1 |
| chr9_-_14314066 | 5.47 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
| chr1_+_230202936 | 5.40 |
ENST00000366672.4
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
| chr4_-_176923483 | 5.36 |
ENST00000280187.7
ENST00000512509.1 |
GPM6A
|
glycoprotein M6A |
| chr5_-_121413974 | 5.34 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
| chr6_-_16761678 | 5.28 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
| chrX_-_6146876 | 5.13 |
ENST00000381095.3
|
NLGN4X
|
neuroligin 4, X-linked |
| chr3_-_33138286 | 5.10 |
ENST00000416695.2
ENST00000342462.4 ENST00000399402.3 |
TMPPE
GLB1
|
transmembrane protein with metallophosphoesterase domain galactosidase, beta 1 |
| chr14_-_68141535 | 5.10 |
ENST00000554659.1
|
VTI1B
|
vesicle transport through interaction with t-SNAREs 1B |
| chr9_+_470288 | 5.07 |
ENST00000382303.1
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
| chr1_+_193091080 | 5.06 |
ENST00000367435.3
|
CDC73
|
cell division cycle 73 |
| chr2_+_169312350 | 5.04 |
ENST00000305747.6
|
CERS6
|
ceramide synthase 6 |
| chr21_-_16437255 | 5.01 |
ENST00000400199.1
ENST00000400202.1 |
NRIP1
|
nuclear receptor interacting protein 1 |
| chr4_-_99851766 | 4.98 |
ENST00000450253.2
|
EIF4E
|
eukaryotic translation initiation factor 4E |
| chr8_-_49833978 | 4.93 |
ENST00000020945.1
|
SNAI2
|
snail family zinc finger 2 |
| chr8_+_107670064 | 4.85 |
ENST00000312046.6
|
OXR1
|
oxidation resistance 1 |
| chr15_+_41709302 | 4.85 |
ENST00000389629.4
|
RTF1
|
Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) |
| chr1_+_35734562 | 4.81 |
ENST00000314607.6
ENST00000373297.2 |
ZMYM4
|
zinc finger, MYM-type 4 |
| chr1_-_245027833 | 4.77 |
ENST00000444376.2
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) |
| chr9_+_80912059 | 4.76 |
ENST00000347159.2
ENST00000376588.3 |
PSAT1
|
phosphoserine aminotransferase 1 |
| chr20_+_31407692 | 4.74 |
ENST00000375571.5
|
MAPRE1
|
microtubule-associated protein, RP/EB family, member 1 |
| chr5_-_111093406 | 4.71 |
ENST00000379671.3
|
NREP
|
neuronal regeneration related protein |
| chr9_+_100745615 | 4.70 |
ENST00000339399.4
|
ANP32B
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
| chr20_-_52210368 | 4.70 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
| chr7_+_73703728 | 4.70 |
ENST00000361545.5
ENST00000223398.6 |
CLIP2
|
CAP-GLY domain containing linker protein 2 |
| chr5_-_98262240 | 4.68 |
ENST00000284049.3
|
CHD1
|
chromodomain helicase DNA binding protein 1 |
| chr10_-_5855350 | 4.65 |
ENST00000456041.1
ENST00000380181.3 ENST00000418688.1 ENST00000380132.4 ENST00000609712.1 ENST00000380191.4 |
GDI2
|
GDP dissociation inhibitor 2 |
| chr5_-_137911049 | 4.56 |
ENST00000297185.3
|
HSPA9
|
heat shock 70kDa protein 9 (mortalin) |
| chr14_-_34931458 | 4.54 |
ENST00000298130.4
|
SPTSSA
|
serine palmitoyltransferase, small subunit A |
| chr7_+_6414128 | 4.54 |
ENST00000348035.4
ENST00000356142.4 |
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
| chrX_+_41192595 | 4.50 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
| chr2_+_231577532 | 4.50 |
ENST00000258418.5
|
CAB39
|
calcium binding protein 39 |
| chrX_-_15872914 | 4.47 |
ENST00000380291.1
ENST00000545766.1 ENST00000421527.2 ENST00000329235.2 |
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit |
| chr3_+_33155444 | 4.40 |
ENST00000320954.6
|
CRTAP
|
cartilage associated protein |
| chr2_+_99953816 | 4.40 |
ENST00000289371.6
|
EIF5B
|
eukaryotic translation initiation factor 5B |
| chr12_+_1800179 | 4.39 |
ENST00000357103.4
|
ADIPOR2
|
adiponectin receptor 2 |
| chr10_-_81205373 | 4.36 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
| chr17_+_57274914 | 4.32 |
ENST00000582004.1
ENST00000577660.1 |
PRR11
CTD-2510F5.6
|
proline rich 11 Uncharacterized protein |
| chr11_-_66115032 | 4.30 |
ENST00000311181.4
|
B3GNT1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1 |
| chr5_+_102201430 | 4.29 |
ENST00000438793.3
ENST00000346918.2 |
PAM
|
peptidylglycine alpha-amidating monooxygenase |
| chr3_+_128444965 | 4.25 |
ENST00000265062.3
|
RAB7A
|
RAB7A, member RAS oncogene family |
| chr17_+_30469473 | 4.19 |
ENST00000333942.6
ENST00000358365.3 ENST00000583994.1 ENST00000545287.2 |
RHOT1
|
ras homolog family member T1 |
| chr6_+_160390102 | 4.12 |
ENST00000356956.1
|
IGF2R
|
insulin-like growth factor 2 receptor |
| chr8_-_130951940 | 4.07 |
ENST00000522250.1
ENST00000522941.1 ENST00000522746.1 ENST00000520204.1 ENST00000519070.1 ENST00000520254.1 ENST00000519824.2 ENST00000519540.1 |
FAM49B
|
family with sequence similarity 49, member B |
| chr21_+_17102311 | 4.04 |
ENST00000285679.6
ENST00000351097.5 ENST00000285681.2 ENST00000400183.2 |
USP25
|
ubiquitin specific peptidase 25 |
| chr14_-_104029013 | 4.03 |
ENST00000299204.4
ENST00000557666.1 |
BAG5
|
BCL2-associated athanogene 5 |
| chr9_+_114659046 | 4.02 |
ENST00000374279.3
|
UGCG
|
UDP-glucose ceramide glucosyltransferase |
| chr3_+_101292939 | 3.99 |
ENST00000265260.3
ENST00000469941.1 ENST00000296024.5 |
PCNP
|
PEST proteolytic signal containing nuclear protein |
| chrX_+_146993449 | 3.93 |
ENST00000218200.8
ENST00000370471.3 ENST00000370477.1 |
FMR1
|
fragile X mental retardation 1 |
| chr7_-_41742697 | 3.86 |
ENST00000242208.4
|
INHBA
|
inhibin, beta A |
| chr12_-_118797475 | 3.83 |
ENST00000541786.1
ENST00000419821.2 ENST00000541878.1 |
TAOK3
|
TAO kinase 3 |
| chr7_+_128379346 | 3.83 |
ENST00000535011.2
ENST00000542996.2 ENST00000535623.1 ENST00000538546.1 ENST00000249364.4 ENST00000449187.2 |
CALU
|
calumenin |
| chr1_-_231560790 | 3.81 |
ENST00000366641.3
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1 |
| chr11_+_118477144 | 3.76 |
ENST00000361417.2
|
PHLDB1
|
pleckstrin homology-like domain, family B, member 1 |
| chr6_+_17600576 | 3.73 |
ENST00000259963.3
|
FAM8A1
|
family with sequence similarity 8, member A1 |
| chr2_-_216300784 | 3.71 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
| chr13_-_107187462 | 3.66 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
| chr10_-_88281494 | 3.65 |
ENST00000298767.5
|
WAPAL
|
wings apart-like homolog (Drosophila) |
| chr16_+_53088885 | 3.62 |
ENST00000566029.1
ENST00000447540.1 |
CHD9
|
chromodomain helicase DNA binding protein 9 |
| chr3_+_120461484 | 3.58 |
ENST00000484715.1
ENST00000469772.1 ENST00000283875.5 ENST00000492959.1 |
GTF2E1
|
general transcription factor IIE, polypeptide 1, alpha 56kDa |
| chr17_+_30264014 | 3.51 |
ENST00000322652.5
ENST00000580398.1 |
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit |
| chr12_-_29534074 | 3.49 |
ENST00000546839.1
ENST00000360150.4 ENST00000552155.1 ENST00000550353.1 ENST00000548441.1 ENST00000552132.1 |
ERGIC2
|
ERGIC and golgi 2 |
| chr1_+_93544791 | 3.43 |
ENST00000545708.1
ENST00000540243.1 ENST00000370298.4 |
MTF2
|
metal response element binding transcription factor 2 |
| chr16_-_67281413 | 3.40 |
ENST00000258201.4
|
FHOD1
|
formin homology 2 domain containing 1 |
| chr6_+_4890226 | 3.38 |
ENST00000343762.5
|
CDYL
|
chromodomain protein, Y-like |
| chr2_-_9770706 | 3.36 |
ENST00000381844.4
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
| chrX_-_23926004 | 3.33 |
ENST00000379226.4
ENST00000379220.3 |
APOO
|
apolipoprotein O |
| chr8_-_17104356 | 3.30 |
ENST00000361272.4
ENST00000523917.1 |
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
| chr12_+_79258547 | 3.29 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
| chrX_+_11129388 | 3.27 |
ENST00000321143.4
ENST00000380763.3 ENST00000380762.4 |
HCCS
|
holocytochrome c synthase |
| chr12_-_123011536 | 3.18 |
ENST00000331738.7
ENST00000354654.2 |
RSRC2
|
arginine/serine-rich coiled-coil 2 |
| chr3_-_125313934 | 3.15 |
ENST00000296220.5
|
OSBPL11
|
oxysterol binding protein-like 11 |
| chr3_-_52312636 | 3.15 |
ENST00000296490.3
|
WDR82
|
WD repeat domain 82 |
| chr7_+_77166592 | 3.10 |
ENST00000248594.6
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
| chr1_+_200708671 | 3.01 |
ENST00000358823.2
|
CAMSAP2
|
calmodulin regulated spectrin-associated protein family, member 2 |
| chr1_+_77333117 | 2.99 |
ENST00000477717.1
|
ST6GALNAC5
|
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
| chr9_-_15510989 | 2.96 |
ENST00000380715.1
ENST00000380716.4 ENST00000380738.4 ENST00000380733.4 |
PSIP1
|
PC4 and SFRS1 interacting protein 1 |
| chr20_-_48770244 | 2.93 |
ENST00000371650.5
ENST00000371652.4 ENST00000557021.1 |
TMEM189
|
transmembrane protein 189 |
| chr3_+_150126101 | 2.84 |
ENST00000361875.3
ENST00000361136.2 |
TSC22D2
|
TSC22 domain family, member 2 |
| chr17_-_60142609 | 2.83 |
ENST00000397786.2
|
MED13
|
mediator complex subunit 13 |
| chr17_-_13505219 | 2.79 |
ENST00000284110.1
|
HS3ST3A1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 |
| chr4_-_83295103 | 2.76 |
ENST00000313899.7
ENST00000352301.4 ENST00000509107.1 ENST00000353341.4 ENST00000541060.1 |
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) |
| chr3_-_27498235 | 2.74 |
ENST00000295736.5
ENST00000428386.1 ENST00000428179.1 |
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
| chr14_+_55518349 | 2.74 |
ENST00000395468.4
|
MAPK1IP1L
|
mitogen-activated protein kinase 1 interacting protein 1-like |
| chr6_+_64281906 | 2.73 |
ENST00000370651.3
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
| chr8_-_48651648 | 2.72 |
ENST00000408965.3
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta |
| chr1_+_32930647 | 2.70 |
ENST00000609129.1
|
ZBTB8B
|
zinc finger and BTB domain containing 8B |
| chr3_-_149688896 | 2.68 |
ENST00000239940.7
|
PFN2
|
profilin 2 |
| chr9_-_74980113 | 2.67 |
ENST00000376962.5
ENST00000376960.4 ENST00000237937.3 |
ZFAND5
|
zinc finger, AN1-type domain 5 |
| chr2_-_122407097 | 2.67 |
ENST00000409078.3
|
CLASP1
|
cytoplasmic linker associated protein 1 |
| chr11_+_35684288 | 2.66 |
ENST00000299413.5
|
TRIM44
|
tripartite motif containing 44 |
| chr13_-_103451307 | 2.65 |
ENST00000376004.4
|
KDELC1
|
KDEL (Lys-Asp-Glu-Leu) containing 1 |
| chr13_-_36920420 | 2.62 |
ENST00000438666.2
|
SPG20
|
spastic paraplegia 20 (Troyer syndrome) |
| chr17_+_72983674 | 2.62 |
ENST00000337231.5
|
CDR2L
|
cerebellar degeneration-related protein 2-like |
| chr13_-_33859819 | 2.61 |
ENST00000336934.5
|
STARD13
|
StAR-related lipid transfer (START) domain containing 13 |
| chr12_-_31479045 | 2.61 |
ENST00000539409.1
ENST00000395766.1 |
FAM60A
|
family with sequence similarity 60, member A |
| chr1_+_51701924 | 2.60 |
ENST00000242719.3
|
RNF11
|
ring finger protein 11 |
| chr15_-_49338748 | 2.60 |
ENST00000559471.1
|
SECISBP2L
|
SECIS binding protein 2-like |
| chr5_-_133968529 | 2.59 |
ENST00000402673.2
|
SAR1B
|
SAR1 homolog B (S. cerevisiae) |
| chr8_-_13372395 | 2.58 |
ENST00000276297.4
ENST00000511869.1 |
DLC1
|
deleted in liver cancer 1 |
| chr1_-_235491462 | 2.58 |
ENST00000418304.1
ENST00000264183.3 ENST00000349213.3 |
ARID4B
|
AT rich interactive domain 4B (RBP1-like) |
| chr14_-_53417732 | 2.56 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
| chr6_+_163835669 | 2.53 |
ENST00000453779.2
ENST00000275262.7 ENST00000392127.2 ENST00000361752.3 |
QKI
|
QKI, KH domain containing, RNA binding |
| chr7_+_69064300 | 2.51 |
ENST00000342771.4
|
AUTS2
|
autism susceptibility candidate 2 |
| chr11_+_9685604 | 2.51 |
ENST00000447399.2
ENST00000318950.6 |
SWAP70
|
SWAP switching B-cell complex 70kDa subunit |
| chr14_+_29234870 | 2.50 |
ENST00000382535.3
|
FOXG1
|
forkhead box G1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of AAUACUG
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.7 | 5.7 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 4.3 | 17.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 4.2 | 16.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 3.9 | 11.8 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 3.8 | 11.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 3.7 | 22.0 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 3.1 | 15.7 | GO:2001074 | regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 2.5 | 2.5 | GO:0035801 | adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 2.3 | 14.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 2.3 | 7.0 | GO:0021966 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) corticospinal neuron axon guidance(GO:0021966) regulation of negative chemotaxis(GO:0050923) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 2.3 | 13.7 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 2.3 | 6.8 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.2 | 8.8 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 2.1 | 39.2 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 2.1 | 12.3 | GO:0032328 | alanine transport(GO:0032328) |
| 2.0 | 6.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 2.0 | 16.0 | GO:0015825 | L-serine transport(GO:0015825) |
| 2.0 | 20.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 2.0 | 6.0 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 1.9 | 3.8 | GO:0033121 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 1.7 | 8.6 | GO:0097338 | response to clozapine(GO:0097338) |
| 1.7 | 10.2 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.7 | 5.1 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 1.6 | 6.5 | GO:0048749 | compound eye development(GO:0048749) |
| 1.6 | 27.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 1.6 | 9.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 1.6 | 4.7 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.5 | 4.5 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 1.5 | 4.5 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 1.5 | 4.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 1.5 | 8.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 1.4 | 4.2 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 1.4 | 5.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.3 | 5.4 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 1.3 | 4.0 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 1.3 | 6.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 1.3 | 3.9 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.2 | 23.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 1.2 | 3.7 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 1.2 | 7.1 | GO:0060613 | fat pad development(GO:0060613) |
| 1.2 | 9.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 1.1 | 4.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 1.1 | 3.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 1.1 | 3.3 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 1.1 | 11.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 1.1 | 4.3 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 1.0 | 2.0 | GO:1901909 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.0 | 6.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 1.0 | 3.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 1.0 | 4.8 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
| 0.9 | 6.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.9 | 2.8 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.9 | 10.6 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.9 | 2.6 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
| 0.8 | 2.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.8 | 6.6 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.8 | 4.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.8 | 11.7 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.8 | 5.5 | GO:0021740 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.7 | 6.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.7 | 15.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.7 | 5.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.7 | 5.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.7 | 2.1 | GO:0021764 | amygdala development(GO:0021764) |
| 0.7 | 7.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.7 | 9.9 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.7 | 4.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.7 | 5.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.7 | 5.5 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.7 | 3.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.7 | 4.1 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.7 | 4.0 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.7 | 2.0 | GO:0038190 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.7 | 7.9 | GO:0007379 | segment specification(GO:0007379) |
| 0.7 | 1.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.7 | 8.5 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.7 | 2.6 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.7 | 7.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.7 | 2.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.6 | 6.5 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.6 | 2.5 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.6 | 2.5 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
| 0.6 | 9.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.6 | 1.8 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.6 | 4.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.6 | 4.6 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.6 | 1.7 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.6 | 5.0 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.5 | 4.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.5 | 2.1 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.5 | 5.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.5 | 8.3 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.5 | 1.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.5 | 3.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.5 | 6.9 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.5 | 3.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.4 | 5.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.4 | 19.6 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.4 | 2.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.4 | 3.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.4 | 1.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.4 | 1.6 | GO:0071373 | cellular response to cocaine(GO:0071314) cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.4 | 2.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.4 | 2.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.4 | 1.5 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.4 | 5.0 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.4 | 1.1 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.3 | 3.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.3 | 1.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.3 | 2.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.3 | 2.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 | 1.3 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.3 | 1.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.3 | 1.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 1.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.3 | 2.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.3 | 1.7 | GO:1990090 | cellular response to nerve growth factor stimulus(GO:1990090) |
| 0.3 | 2.0 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.3 | 3.7 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
| 0.3 | 4.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.3 | 5.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.3 | 2.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.3 | 2.6 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.3 | 1.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.3 | 1.8 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 | 0.3 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.3 | 2.5 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.3 | 1.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 0.5 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.2 | 12.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.2 | 1.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.2 | 1.2 | GO:0051582 | peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.2 | 8.9 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.2 | 3.5 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.2 | 2.7 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.2 | 2.4 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 | 2.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 | 6.8 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.2 | 1.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 | 4.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 | 5.2 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.2 | 1.2 | GO:0072719 | copper ion import(GO:0015677) cellular response to cisplatin(GO:0072719) |
| 0.2 | 1.5 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 1.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 7.0 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.2 | 1.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.2 | 3.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.2 | 2.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 6.5 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.2 | 0.7 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 | 15.7 | GO:0032392 | DNA geometric change(GO:0032392) |
| 0.2 | 3.1 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.2 | 0.6 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.2 | 1.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.2 | 0.5 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.2 | 9.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.2 | 3.8 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 8.0 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.1 | 7.4 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.1 | 11.5 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.1 | 0.5 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 | 1.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 1.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 6.7 | GO:0019835 | cytolysis(GO:0019835) |
| 0.1 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 | 2.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.1 | 3.3 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.1 | 1.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.1 | 1.0 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 | 2.0 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 1.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 | 0.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) righting reflex(GO:0060013) |
| 0.1 | 1.0 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.1 | 4.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.6 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 | 5.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.1 | 2.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 1.6 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.1 | 3.6 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.3 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 | 3.3 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.4 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 2.8 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.1 | 1.3 | GO:0008105 | asymmetric protein localization(GO:0008105) |
| 0.1 | 1.0 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 0.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 | 5.1 | GO:0030316 | osteoclast differentiation(GO:0030316) |
| 0.1 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 | 8.8 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 0.1 | 4.1 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.1 | 2.0 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.1 | 0.5 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.1 | 0.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.3 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
| 0.1 | 2.7 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.1 | 0.3 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.1 | 1.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 2.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.1 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 | 1.2 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 4.4 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.1 | 0.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.1 | 1.3 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
| 0.1 | 1.9 | GO:0016577 | histone demethylation(GO:0016577) |
| 0.1 | 0.2 | GO:2000705 | histone H3-T6 phosphorylation(GO:0035408) dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 | 2.0 | GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) |
| 0.1 | 2.1 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.0 | 0.6 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.0 | 0.5 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 | 0.9 | GO:0045055 | regulated exocytosis(GO:0045055) |
| 0.0 | 5.5 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
| 0.0 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.0 | 3.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.0 | 0.6 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.0 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 | 1.9 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
| 0.0 | 1.1 | GO:0097435 | fibril organization(GO:0097435) |
| 0.0 | 0.1 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
| 0.0 | 0.2 | GO:0060685 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.0 | 0.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.0 | 1.4 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.0 | 0.6 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.0 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 2.6 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 2.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.0 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.0 | 0.8 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.0 | 2.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 0.1 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.0 | 0.6 | GO:0021884 | forebrain neuron development(GO:0021884) |
| 0.0 | 0.8 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 | 10.4 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.0 | 1.6 | GO:0042255 | ribosome assembly(GO:0042255) |
| 0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
| 0.0 | 0.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 2.1 | GO:0051168 | nuclear export(GO:0051168) |
| 0.0 | 0.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.0 | 0.1 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.0 | 0.0 | GO:0017145 | stem cell division(GO:0017145) |
| 0.0 | 2.8 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.0 | 0.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.0 | 0.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 | 1.5 | GO:1903509 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
| 0.0 | 0.1 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.0 | 0.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.0 | 2.8 | GO:0006457 | protein folding(GO:0006457) |
| 0.0 | 4.2 | GO:0010608 | posttranscriptional regulation of gene expression(GO:0010608) |
| 0.0 | 0.3 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.0 | 0.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 10.2 | GO:0044393 | microspike(GO:0044393) |
| 3.4 | 13.4 | GO:0043260 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) laminin-11 complex(GO:0043260) |
| 2.0 | 6.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 2.0 | 15.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 1.8 | 7.2 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 1.6 | 11.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 1.4 | 13.6 | GO:0045180 | basal cortex(GO:0045180) |
| 1.3 | 3.9 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 1.2 | 6.2 | GO:0035061 | interchromatin granule(GO:0035061) |
| 1.2 | 9.5 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 1.2 | 3.6 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 1.2 | 4.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 1.1 | 16.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 1.1 | 5.6 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 1.1 | 5.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 1.0 | 22.0 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.0 | 9.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.9 | 7.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.9 | 17.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.8 | 5.7 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.8 | 12.1 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.8 | 12.9 | GO:0043073 | germ cell nucleus(GO:0043073) |
| 0.7 | 5.7 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.7 | 8.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.7 | 3.5 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.7 | 14.0 | GO:0042599 | lamellar body(GO:0042599) |
| 0.7 | 3.3 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.6 | 11.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.6 | 19.7 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.5 | 5.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.5 | 10.4 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.5 | 5.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.5 | 10.4 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.5 | 3.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.5 | 5.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.5 | 5.0 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.4 | 19.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.4 | 2.3 | GO:0098797 | plasma membrane protein complex(GO:0098797) |
| 0.4 | 4.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.4 | 2.2 | GO:0002177 | manchette(GO:0002177) |
| 0.3 | 3.8 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.3 | 9.0 | GO:1990752 | microtubule end(GO:1990752) |
| 0.3 | 1.9 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.3 | 4.4 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.3 | 7.1 | GO:0030904 | retromer complex(GO:0030904) |
| 0.3 | 3.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.3 | 2.4 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.3 | 1.5 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.2 | 1.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.2 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.2 | 11.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.2 | 30.2 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.2 | 4.9 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.2 | 17.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 40.3 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.2 | 3.4 | GO:0032059 | bleb(GO:0032059) |
| 0.2 | 1.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 20.8 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.2 | 6.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.2 | 1.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 2.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.2 | 6.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 3.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.2 | 1.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
| 0.2 | 0.9 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 12.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 1.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.1 | 4.3 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 0.7 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 9.2 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 11.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 18.9 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 9.8 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.1 | 0.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 3.2 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 5.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 10.1 | GO:0005903 | brush border(GO:0005903) |
| 0.1 | 12.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 10.4 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 4.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 2.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 6.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 27.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.1 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.1 | 8.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 4.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 2.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 1.3 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.1 | 1.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.1 | 10.8 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 7.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 29.6 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 1.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 1.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 2.7 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 7.4 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.0 | 1.5 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.0 | 1.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.0 | 10.3 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 1.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 3.4 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 3.9 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.0 | 4.0 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 2.8 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 12.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 1.2 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.0 | 1.2 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
| 0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.0 | 1.3 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.0 | 1.3 | GO:0036126 | sperm flagellum(GO:0036126) |
| 0.0 | 5.0 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.0 | 8.8 | GO:0005774 | vacuolar membrane(GO:0005774) |
| 0.0 | 3.0 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 1.0 | GO:0030496 | midbody(GO:0030496) |
| 0.0 | 1.4 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.0 | 0.3 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.0 | 0.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 2.5 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 1.3 | GO:0098793 | presynapse(GO:0098793) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.3 | 10.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 2.4 | 16.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 1.8 | 9.2 | GO:0034046 | poly(G) binding(GO:0034046) |
| 1.6 | 11.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 1.5 | 4.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 1.5 | 7.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 1.5 | 6.0 | GO:0038025 | glycoprotein transporter activity(GO:0034437) reelin receptor activity(GO:0038025) |
| 1.3 | 16.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 1.3 | 3.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 1.3 | 5.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 1.2 | 7.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 1.1 | 10.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 1.1 | 5.5 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 1.1 | 8.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 1.1 | 5.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 1.1 | 4.3 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 1.0 | 2.0 | GO:0050072 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) m7G(5')pppN diphosphatase activity(GO:0050072) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 1.0 | 3.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.0 | 5.9 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.9 | 10.6 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.9 | 10.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.8 | 5.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.8 | 20.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.7 | 2.1 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.7 | 2.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.7 | 4.1 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.7 | 2.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.7 | 3.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.6 | 17.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.6 | 5.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.6 | 3.0 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.6 | 2.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.6 | 11.3 | GO:0008603 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.6 | 40.7 | GO:0019003 | GDP binding(GO:0019003) |
| 0.6 | 11.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.5 | 8.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.5 | 1.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.5 | 6.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.5 | 7.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.4 | 10.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.4 | 8.3 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.4 | 2.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.4 | 2.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.4 | 8.5 | GO:0043495 | protein anchor(GO:0043495) |
| 0.4 | 10.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.4 | 29.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.4 | 1.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.4 | 3.3 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.4 | 11.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.4 | 3.5 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.4 | 8.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.4 | 5.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.4 | 1.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.4 | 4.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 6.7 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.4 | 5.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.4 | 6.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.3 | 1.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.3 | 1.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.3 | 2.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.3 | 4.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.3 | 2.0 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.3 | 5.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.3 | 1.6 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.3 | 3.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.3 | 6.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.3 | 5.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.3 | 16.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.3 | 5.5 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.3 | 6.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.3 | 1.2 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.3 | 3.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 1.7 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.3 | 2.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 5.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 1.9 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.3 | 1.5 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.2 | 13.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.2 | 1.6 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.2 | 4.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.2 | 1.9 | GO:0043426 | MRF binding(GO:0043426) |
| 0.2 | 2.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.2 | 33.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 3.4 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.2 | 2.8 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 3.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.2 | 9.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 3.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 5.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.2 | 0.2 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.2 | 5.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.2 | 1.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 3.6 | GO:0004386 | helicase activity(GO:0004386) |
| 0.2 | 1.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.2 | 48.7 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.2 | 11.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.2 | 1.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 1.8 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 23.2 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 4.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 4.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 12.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 2.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.1 | 2.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.1 | 22.2 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 2.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.1 | 1.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.1 | 2.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 22.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 2.0 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.1 | 0.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 11.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.1 | 2.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.1 | 2.4 | GO:0032452 | histone demethylase activity(GO:0032452) |
| 0.1 | 1.1 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 2.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.1 | 1.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.1 | 1.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.1 | 7.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.1 | 0.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.1 | 3.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 1.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.1 | 5.3 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
| 0.1 | 5.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 2.6 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.1 | 16.1 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.6 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 1.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.0 | 0.2 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 1.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.0 | 1.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 4.5 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 2.8 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.0 | 4.6 | GO:0017124 | SH3 domain binding(GO:0017124) |
| 0.0 | 1.4 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.0 | 0.2 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.0 | 2.6 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 1.9 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.0 | 1.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 10.4 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 0.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.0 | 0.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.0 | 1.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 4.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.6 | 38.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.6 | 20.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.6 | 13.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.5 | 28.8 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.5 | 19.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.4 | 14.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.4 | 19.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.3 | 12.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 19.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.3 | 13.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.3 | 17.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.3 | 16.5 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 13.6 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 3.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.1 | 14.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 1.8 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 6.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.1 | 2.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 5.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.1 | 12.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 3.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 7.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 1.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 8.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 2.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 2.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 2.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 2.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 2.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 3.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 1.1 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 3.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.0 | 2.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 1.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.0 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.0 | 1.5 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.0 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 1.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.0 | 0.9 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.0 | 6.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.6 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 0.5 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.4 | 14.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 1.2 | 4.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 1.0 | 23.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.9 | 8.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.9 | 12.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.8 | 33.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.8 | 16.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.7 | 32.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.6 | 1.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
| 0.5 | 12.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.5 | 13.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.5 | 12.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.5 | 6.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.4 | 10.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.4 | 13.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.4 | 1.8 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.4 | 5.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.3 | 3.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.3 | 10.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.3 | 4.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.3 | 10.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.3 | 5.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.3 | 5.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.3 | 3.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.3 | 5.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.3 | 5.2 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.2 | 2.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.2 | 8.5 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.2 | 1.9 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
| 0.2 | 10.9 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
| 0.2 | 17.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.2 | 4.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.2 | 10.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 5.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 1.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 5.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 3.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 7.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 7.6 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 2.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.1 | 2.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 4.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.1 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 3.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.1 | 3.3 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
| 0.1 | 3.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 2.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 6.4 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 1.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 1.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 5.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 6.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
| 0.1 | 2.7 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.1 | 2.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 10.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 4.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 1.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.1 | 1.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 1.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.0 | 0.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 0.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 0.0 | 6.2 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.0 | 3.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 3.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.0 | 0.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.0 | 1.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 1.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.9 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.0 | 1.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 2.2 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.0 | 1.3 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |